4.5 Article

microRNA-155 regulates cell proliferation and invasion by targeting FOXO3a in glioma

期刊

ONCOLOGY REPORTS
卷 30, 期 5, 页码 2111-2118

出版社

SPANDIDOS PUBL LTD
DOI: 10.3892/or.2013.2685

关键词

glioma; miR-155; FOXO3; proliferation; invasion

类别

资金

  1. Program for New Century Excellent Talents in University [NCET-09-0165]
  2. Jiangsu Province's Key Provincial Talents Program [RC2011106]
  3. '333' Project of Jiangsu Province Government
  4. Soochow Scholar Project of Soochow University
  5. Suzhou Key Laboratory for Molecular Cancer Genetics [SZS201209]

向作者/读者索取更多资源

microRNAs (miRNAs) are short noncoding RNAs, which modulate the expression of numerous genes by targeting mRNAs. Numerous abnormal miRNA expression patterns are found in various human malignancies, and certain miRNAs act as oncogenes or tumor suppressors. microRNA-155 (miR-155) may not only function as an oncogene but also as a tumor suppressor in various types of cancer cells, such as melanoma. Although miR-155 has been found to be upregulated in glioma, its role has not yet been eludicated in glioma tumorigenesis. Based on the prediction of the target genes of miR-155, we hypothesized that there is a significant association between miR-155 and FOXO3a, a negative regulator of Akt signaling. In the present study, we found that FOXO3a expression was significantly downregulated and miR-155 was upregulated in a panel of glioma cells and tissue specimens. Furthermore, we demonstrated that miR-155 induced cell proliferation by inhibiting apoptosis and promoted the migration and invasiveness of glioma cells, while miR-155 had no effect on the cell cycle as determined by gain-of-function and loss-of-function experiments. Moreover, we confirmed that miR-155 downregulated the expression of FOXO3a by directly targeting its 3'-UTR. These findings indicate that miR-155 may function as an oncogene by targeting FOXO3a in the development and progression of glioma.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据